Poor People’s Campaign releases response to needs of 140 million poor, low-income people 

The Poor People’s Campaign: A National Call for Moral Revival is releasing a comprehensive policy platform designed to heal the nation on Saturday in conjunction with its digital social justice assembly. 

The Poor People’s Moral Justice Jubilee Policy Platform is a sweeping, transformational response to the needs and demands of the 140 million people who are poor or low-income and are struggling to make ends meet in this country. In the richest country in the world, 700 people a day die from poverty – 250,000 people a year. Those numbers were a reality even before COVID-19. The Poor People’s Campaign centers its demands around the five interlocking injustices of systemic racism, systemic poverty, ecological devastation, the war economy and militarism and a distorted moral narrative of religious nationalism.

“This is not a left or right agenda, but a moral fusion agenda, rooted in our deepest moral and Constitutional values,” said Rev. Dr. William J. Barber II, co-chair of the Campaign. “This agenda makes it clear that the failure to address the interlocking injustices costs lives and is morally indefensible, constitutionally inconsistent and economically insane.”

The platform is being released at 7 a.m. Saturday, June 20, ahead of the Campaign’s digital Mass Poor People’s Assembly and Moral March on Washington. 

It indicates the Campaign’s policy and legislative priorities around voting rights, police violence, indigenous rights, immigrant rights, education, welfare, jobs, education, housing, water, war, wealth inequality and more. 

“We have been putting this nation’s abundant resources into punishing, criminalizing and killing the poor,” said Rev. Dr. Liz Theoharis, co-chair of the campaign. “We need to be building a society where everybody can survive and, more than that, thrive.” 

After years of organizing across 45 states, the campaign continues to shift the narrative on what is necessary and possible. As the country approaches the July 4th birthday of the nation, the Moral Justice Jubilee Platform takes up the moral and Constitutional values of this country and reminds us all of the country we have yet to be. 

The Campaign is co-sponsored by Repairers of the Breach, whose president is Rev. Dr. William J. Barber II, and the Kairos Center, whose director is Rev. Dr. Liz Theoharis. 

The Moral Justice Jubilee Policy Platform will be available at: http://bit.ly/ppcjubilee

___

 Contact: Martha Waggoner | mwaggoner@breachrepairers.org | 919-295-0802

___ 

Reporters can register here for our virtual press room. 

For additional information: june2020.org / poorpeoplescampaign.org https://youtu.be/PmOjcUoDhEs

Twitter: @unitethepoor / Instagram: @poorpeoplescampaign / Facebook: @ANewPPC

 ___The Poor People’s Campaign: A National Call for Moral Revival, is building a generationally transformative digital gathering called the  Mass Poor People’s Assembly and Moral March on Washington, on June 20, 2020. At that assembly, we will demand that both major political parties address the interlocking injustices of systemic racism, poverty, ecological devastation, militarism and the distorted moral narrative of religious nationalism by implementing our Moral Agenda.

NCOA Study: 3 Million Low-Income Older Adults Face 
Systemic Obstacles to Programs that Help Pay for Health Care

Policy solutions would make access to benefits easier for low-income individuals

Arlington, VA, June 22, 2020 — Today, the National Council on Aging (NCOA), a trusted national leader working to ensure that every person can age well, issued a study analyzing the systemic obstacles that keep nearly 3 million eligible older adults and people with disabilities from accessing programs designed to help pay for their health care and medicine. The issue brief also offers policy solutions to ensure that all eligible low-income individuals receive this critical assistance. 

Millions of financially vulnerable older adults and people with disabilities who have trouble affording prescription drugs and health care qualify for Medicare Savings Programs (MSPs), which help pay for Medicare premiums and cost sharing, and the Medicare Part D Low-Income Subsidy (LIS) (also known as Extra Help), which helps pay for prescription drugs. However, almost 3 million of these eligible individuals are not enrolled in the programs. 

The issue brief estimates eligibility, enrollment, and take-up rates in MSPs and LIS among the age 65 and older non-institutionalized population for even years between 2008 and 2014.

“About two-thirds of people eligible for MSPs are enrolled, but another 2.5 million Medicare beneficiaries are missing out on the benefits of this program,” said Dr. Susan Silberman, NCOA Senior Director, Research and Evaluation. “While some of these individuals may be making an informed decision to not apply, many are unaware that they are eligible or have found the enrollment process too intimidating to attempt or too difficult to complete.”

NCOA recommends a range of policy solutions that would improve access to these important Medicare low-income assistance programs. They include:

  • Loosening eligibility standards, which can have the dual effect of making more people eligible and making enrollment easier
  • Aligning eligibility standards more closely across programs, particularly between MSP and Part D LIS
  • Simplifying the enrollment process to make signing up as automatic as possible
  • Allocating more resources for benefits outreach and enrollment to find and assist eligible individuals in applying for the programs

The complete issue brief, Take-Up Rates in Medicare Savings Programs and the Part D Low-Income Subsidy Among Community-Dwelling Medicare Beneficiaries Age 65 and Older, is available online.

About NCOA

The National Council on Aging (NCOA) is a trusted national leader working to ensure that every person can age well. Since 1950, our mission has not changed: Improve the lives of millions of older adults, especially those who are struggling. NCOA empowers people with the best solutions to improve their own health and economic security—and we strengthen government programs that we all depend on as we age. Every year, millions of people use our signature programs BenefitsCheckUp®, My Medicare Matters®, and the Aging Mastery Program® to age well. By offering online tools and collaborating with a nationwide network of partners, NCOA is working to improve the lives of 40 million older adults by 2030. Learn more at ncoa.org and @NCOAging.

Temporary Isolation Can Be The Opportunity To Permanently Transform Your Weight And Health
 

Los Angeles, CA, June 22, 2020  ̶  Not sure how to eat and stay healthy this quarantine season without resorting to your familiar diet of spaghetti, bread, pizza, and sugar? Candice Rosen, R.N., MSW, and author of the upcoming book Forget Dieting: It’s All About Data-Driven Fueling!  encourages "trophology," or "food combining," which is one of the foundations of Rosen's Data-Driven Fueling Plan. As you combine foods, Rosen adds that "monitoring blood glucose is the key to weight gain vs. weight loss; good health vs. poor health."

1. Make Wednesdays and Fridays Vegan Days. According to Rosen, avoid dairy! Try vegan yogurts, cheeses, and milks. Dairy is inflammatory and will deplete your bones of calcium (it’s true!). There are unsweetened milks of almond, hemp, cashew, etc., and all are available in grocery stores. A low blood glucose breakfast idea would be a sprouted grain English muffin, spread with a tofu or nut-based cream cheese, some sliced tomatoes, and topped off with sea salt or Trader Joe’s Everything But The Bagel Sesame Seasoning Blend. 


2. Eat fruits that are high in fiber. Apples, bananas, oranges, berries  ̶  the list goes on! You will still want to avoid sugary fruit juices, as well as very sweet fruits like pineapples and mangos while trying to lose weight. Fruit is always eaten alone with two exceptions: they can be added to a vegan smoothie and they can be eaten with a nut or seed butter. These healthy fats reduce the chance of a blood glucose spike. 

3. Nothing white. To lower blood glucose, do not eat or combine animal proteins with any white potatoes, bread, rice, or pasta… EVER. Sorry! 

4. Eat More Sweet Potatoes. Think wholesome, nutritious, responsibly grown, pancreatic-friendly foods (food that doesn’t raise your blood glucose) like sweet potatoes and yams, which are an incredibly nutritious carbohydrate that are low in sugar levels and provide fiber. They’re best consumed baked or steamed, but can also be cooked in a variety of other ways. A great lunch or dinner option (and it is inexpensive) is a baked sweet potato, split down the middle with a large spoonful of black beans, a tablespoon of tomatillo salsa, and a side salad. To lower blood sugar, eat them with veggies and plant-based protein together… NOT MEAT!

5.  Try Fish.  Give your body a break from animal protein. Red meats increase inflammation and provide poor sources of fat. However, if you crave protein, try fish! For those who aren’t allergic, fish is a fantastic source of protein that’s low in carbohydrates and contains high amounts of omega-3 fatty acids, one of the few consumable healthy fats! If consuming fish raw, remember only sashimi-style – no white rice! To lower blood sugar, combine fish with veggies, not starches or fruit. 
 

About the author:

Candice P. RosenRN, MSW, CHC, is a registered nurse based in Los Angeles, CA. As the founding member of Gilda’s Club Chicago and its first executive director and program director, she created and coordinated a diverse array of wellness-related programs. She was appointed by Mayor Richard Daley to serve as Chair of Healthcare Initiatives for Chicago’s Sister Cities International Program (CSCIP). CSCIP provided an opportunity to advocate for preventive medicine, improve maternal and infant healthcare, stress disability access, promote nourishing diets, and bring awareness to the obesity and diabetes epidemics that now affect populations on a global level. She is married and the mother of four adult children and grandmother to a precious granddaughter. For more information on Candice, please visit  https://candicerosenrn.com.  

Forget Dieting: It’s All About Data-Driven Fueling! 
Rowman and Littlefield
Release Date: July 2020
Hardcover / $30
ISBN: 978-1-5381-3149-7
Available at: https://www.amazon.com/Forget-Dieting-about-Data-Driven-Fueling/dp/1538131498/ref=sr_1_1?dchild=1&keywords=Forget+Dieting%3A+It%E2%80%99s+All+About+Data-Driven+Fueling%21&qid=1587680221&s=books&sr=1-1

Sahoja Partners with Block-Chain Provider Loyyal

Greatly strengthens the social-media company’s rewards points

ATLANTA – Sahoja (www.sahoja.co) will partner with San Francisco -based Loyyal Corporation which will allow Sahoja’s reward points to be integrated on Loyyal’s blockchain-as-a-service platform. This streamlines complex transactions involving Sahoja’s reward points across multiple loyalty programs and their partners.  

Sahoja and Loyyal will conduct a three-month joint pilot program prior to full implementation.

Sahoja, based here, consists of three digital platforms – social media, a curated marketplace, and an impact platform – all based on doing good. 

According to Sahoja co-founder Rajesh Rai, “These three platforms are brought together by a reward points system underpinned by blockchain technology, where:  

“We envision a world where online communities support our universal longing for connection and make spreading kindness our norm.

“We seek to provide online spaces to make it easy for people, companies, and non-profits to build a better world together - one that puts humanity and the planet first.

“We make ethical and sustainable living easy.

“It shouldn't be so hard to make a difference. Sahoja brings the most conscious companies, high-impact non-profits, and like-minded people to your virtual door. Join us and 10x your impact on the causes that are close to your heart.”

Loyyal brings a very positive approach to this association, according to Gregory Simon, CEO and co-founder.

"We are very excited to invite Sahoja as our latest customer,” he explained. We designed the Loyyal platform to be industry agnostic and one of my personal passions has always been to incentivize social good. Loyyal's blockchain-based technology in combination with Sahoja's unique and innovative program will empower people to help each other and do good."

About Sahoja

Sahoja is a social-media company which combines a social media platform with a philanthropic organization and an e-commerce marketplace utilizing blockchain technology for its rewards system. At its essence, Sahoja is a social network for making a positive impact – no politics or religion is discussed on the platform. In addition, all members will have the opportunity to become owners of the organization.

About Loyyal

Loyyal, the Internet of Loyalty, is reinventing how loyalty is created, rewarded, and managed. Using proprietary blockchain and smart contract technology, Loyyal's interoperable loyalty and rewards platform brings a host of benefits to a highly fragmented industry and offers brands an innovative way to unlock the billions of dollars in value held captive in legacy loyalty programs today. For information about Loyyal, please visit www.loyyal.com or email info@loyyal.com

Momentous Releases Performance Collagen Product Scientifically Proven to Reduce Pain, Support Joint Health, and Increase Cartilage Mass

Beyond hair, skin and nails, Momentous collagen addresses joints, ligaments, chronic pain and injury prevention by combining PEPTIPLUS® and FORTIGEL® collagen with vitamin C 

(Jackson Hole, Wyo.) June 23, 2020 – Momentous, a premium sports nutrition company, is proud to announce the release of a new addition to its product line: Collagen Peptides. Recognizing the problems that joint health presents to athletes, Momentous engineered a unique formula that combines PEPTIPLUS® and FORTIGEL® collagen with vitamin C to accelerate injury recovery, improve connective tissue health and durability, and reduce joint pain. 

“No matter how durable an athlete is, he or she starts losing collagen mass eventually, which can impact the resilience of joints and duration of careers,” said Momentous CEO and founder Matt Wan. “We wanted to create a collagen peptide formula sourced from the highest-quality ingredients, and enhanced with the ability to target joins and ligaments. With Momentous Collagen Peptides, athletes of every age can safeguard their joints, recover faster from injury, and function better on the field and in everyday life.” 

Collagen is a protein fiber that transmits force, absorbs energy, and is found in connective tissues such as cartilage (70 percent of which is collagen), tendons, bones, skin, and ligaments. As we age, both collagen mass and synthesis decrease. This is bad enough for the 25 percent of American adults who struggle with joint problems, but for athletes, it can predispose them to new injuries, extend rehabilitation of existing ones, and contribute to chronic pain. A decline in joint health can limit performance, compromise vitality, and eventually force an athlete to retire. 

Momentous Collagen Peptides meets these challenges head on, providing a rich source of PEPTIPLUS® collagen sourced from the finest US grass-fed bovine and FORTIGEL® collagen hydrolysate derived from pasture-raised German bovine. FORTIGEL® is scientifically proven to improve the rate of collagen synthesis, reduce joint pain during activity and rest, and increase collagen mass. Momentous added vitamin C to its unique formula because studies show it improves collagen availability. As with Performance CreatineMomentous Sleep, and the company’s line of grass-fed whey and plant-based proteins, Collagen Peptides was developed with a team of Performance Engineers, tested by elite athletes, coaches, and nutritionists, and evaluated by the rigorous NSF Certified for Sport® and Informed Sport programs. 

“Momentous Collagen Peptides is helping me bounce back from my second ACL surgery,” said pro skier and Momentous ambassador Johnny Collinson. “It reduced the pain in my knee and I can tell a difference in how my wrists, elbows, and shoulders feel during and after the upper-body training sessions I’ve been doing to prepare for getting back on the mountain.” 

About Momentous

Momentous was founded in Jackson Hole, Wyoming in 2016 with the goal to empowers the relentless pursuit of progress in athlete health and wellness. We strive to create no-compromise products that support the endless improvement of athletic performance. Our mission drove us to seek out the absolute best knowledge of nutritional supplements in order to be able to deliver formulas with complete transparency and free of fillers and inferior ingredients. Momentous products are NSF Certified for Sport across the line, taste great and perform. Momentous products fuel thousands of professional, collegiate, and youth athletes on their performance journeys. Learn more at www.livemomentous.com

Health Canada approves NexGard® and NexGard Spectra™ for the reduction of Lyme disease

  • NexGard® and NexGard Spectra™ receives Health Canada approval for the reduction of Borrelia burgdorferi (B. burgdorferi) infections as a direct result of killing adult Ixodes scapularis (I. scapularis) vector ticks. B. burgdorferi is the causative agent of Lyme disease. 

BURLINGTON, ON, June 23, 2020 /CNW/ - Boehringer Ingelheim Animal Health Canada Inc. received approval from Health Canada to expand the label claim of NexGard® (afoxolaner) and NexGard Spectra™ (afoxolaner and milbemycin oxime) to include an indication for the reduction of B. burgdorferi infections as a direct result of killing adult I. scapularis vector ticks. B. burgdorferi is the infectious agent which causes Lyme disease in dogs.

NexGard® and NexGard Spectra™ are the first and only parasiticide products in Canada to receive a B. burgdorferiprotection label claim. The label claim applies equally to both products because the concentration of afoxolaner is equivalent in both. This now provides the pet owner with heightened ability to prevent Lyme disease in their dog.

"Boehringer Ingelheim's unwavering commitment to advancing veterinary medicine with a focus on prevention is proudly showcased with this first-ever indication in Canada to reduce the B. burgdorferi infections that cause Lyme disease," says Tyron Hansen, Marketing Manager, Pet, Boehringer Ingelheim Animal Health Canada Inc.  "Providing veterinarians and pet owners with reliable and effective products to keep their animals healthy remains our top priority." 

Boehringer Ingelheim Animal Health
Boehringer Ingelheim is the second largest animal health business in the world, with net sales of 4 billion euros in 2019 and presence in more than 150 markets.

As the lives of animals and humans are intertwined, across the globe, our 10,000 employees are dedicated to enhancing the well-being of both – through science and innovation, as well as with their commitment and passion.

Respect for animals, people and the environment is at the heart of what we do. We develop medicines, services and innovative digital technologies to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society- threatening diseases.

For more information visit: https://www.boehringer-ingelheim.ca/en/animal-health/animal-health-2

Boehringer Ingelheim Canada (Ltd.)
Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros. Our significant investment of almost 3.5 billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life. 

We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.

The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 600 people across Canada.

More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.ca or in our annual report: http://annualreport.boehringer-ingelheim.com

References

1.Baker CF, McCall JW, McCall SD et. al. Ability of an oral formulation of afoxolaner to protect dogs from Borrelia burgdorferi infection transmitted by wildIxodes scapularis ticksComp Immunol Microbio Inf Dis. 2016;49:65-69
2.Boehringer Ingelheim PR&D 0377501

SOURCE Boehringer Ingelheim (Canada) Ltd.

COVID-19 is Hurting Chronic Migraine Care in Canada

June is National Migraine and Headache Awareness Month

TORONTO, June 23, 2020 /CNW/ - Like most chronic conditions, COVID-19 is having an incredible impact on patients living with chronic migraines (CM). Allergan, an AbbVie Company, is proudly supporting National Migraine and Headache Awareness Month encouraging patients and caregivers to share their experiences with #MoreThanAMigraine to encourage dialogue and awareness surrounding chronic migraines, migraines and headaches. 

"The COVID-19 pandemic has been a particularly vulnerable time for individuals with chronic migraines, with many physical and mental stressors, increased anxiety, and changes in daily routine that have served as triggering factors for worsening symptoms. This, combined with limited access to their headache specialists, has resulted in trying times for this patient population to manage their condition," said Dr. Ian Finkelstein, Medical Director at the Toronto Headache & Pain Clinic. "Chronic migraine patients 'walk a tight line' when it comes to managing their symptoms, and COVID-19 has been an impetus in derailing many otherwise well controlled patients. Better diagnosis, management and education surrounding this disabling condition is of paramount importance."

The Difference Between Migraines and Other Types of Headaches
Migraines are more severe and debilitating than other types of headaches, and impact over 2.7 million Canadians.1 They consist of moderately to severely intense headaches with throbbing or pulsating pain and are often on one side of the head.2Other debilitating symptoms include nausea; vomiting; and hypersensitivity to lights, sounds and smells.3

#MoreThanAMigraine
Throughout June, Allergan is encouraging migraine sufferers to break their silence in hopes to spread awareness on the condition, to highlight the symptoms, and qualify disease impact. Patients and caregivers can share their experiences online using #MoreThanAMigraine. A patient self-assessment, triggers and treatment options can be accessed via mychronicmigraine.ca. The site also features a search tool that allows Canadians to find a doctor in their area who may be able to help. Migraine sufferers should speak to their healthcare providers about their quality of life and symptom impact.

Throbbing Statistics 

  • It is estimated that between 370,000- 600,000 adult Canadians, 18 years or older, suffer from CM.4
  • Over 80 per cent of CM sufferers in Canada are women.5
  • It has been estimated that just 20.2 per cent of CM sufferers receive a CM diagnosis, and only 33.3 per cent of CM patients use preventive medication.6
  • Patients with CM are more likely to miss days of work, school, household work, become occupationally disabled and experience lower levels of household income.7,8
  • Patients with CM are nearly twice as likely to be affected by depression or anxiety when compared to episodic migraines.9
  • Patients with CM are more likely to receive opioid medications than those with episodic migraines.10,11

About AbbVie 
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on TwitterFacebookInstagramYouTube and LinkedIn.

________________________________________
1Statistics Canada. Prevalence of migraine in the Canadian household population. Accessed May 2018:  https://www.statcan.gc.ca/pub/82-003-x/2014006/article/14033-eng.htm 
2Natoli JL et al. Global Prevalence of Chronic Migraine: A Systematic Review. Cephalalgia. 2010 May;30 (5):599-609..
3Natoli JL et al. Global Prevalence of Chronic Migraine: A Systematic Review. Cephalalgia. 2010 May;30 (5):599-609.
4Natoli JL et al. Global Prevalence of Chronic Migraine: A Systematic Review. Cephalalgia. 2010 May;30 (5):599-609.
5Stokes M. et al. "Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS)." American Headache Society. 2011 May: 1065. 
6Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71:559-566. doi:10.1212/01.wnl.0000323925.29520.e7.
7Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428-432. doi:10.1136/jnnp.2009.192492.
8Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71:559-566. doi:10.1212/01.wnl.0000323925.29520.e7.
9Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428-432. doi:10.1136/jnnp.2009.192492.
10Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71:559-566. doi:10.1212/01.wnl.0000323925.29520.e7.
11Pavlovic J, Yu J, Silberstein S, et al. Migraine Treatment Patterns and Opioid Use Among Chronic and Episodic Migraine Patients Identified by a Clinician-Administered Semi-Structured Diagnostic Interview (S32.001). Neurology. 2018;90(15 Supplement):S32.001. http://n.neurology.org/content/90/15_Supplement/S32.001. Accessed June 1, 2018.

SOURCE Allergan, an AbbVie Company

Orthopaedic Patients go to Lithuania to Avoid COVID-19 Delays

Image

The COVID-19 pandemic has hit hard on patients waiting for orthopaedic surgeries. Extra delays added up to the already long waiting lists in Canada, the UK, Ireland and other parts of the world. As the borders open, suffering patients seek relief in private clinics abroad.

June 23rd, 2020. A recent study has estimated that the COVID-19 pandemic will cause more than 28 million elective surgeries to be cancelled or postponed worldwide. The largest single block of these are orthopaedic surgeries - more than 6 million procedures likely to be affected. The situation is especially difficult in countries like Canada, the UK or Ireland, where COVID-19 delays add up to the already long pre-pandemic waiting lists.

Moreover, waiting for orthopaedic surgery is very painful. Malfunctioning knees or hips cause strong pain or even inability to walk. Some patients describe waiting for surgery as "life being put on hold.” The suffering pushes these patients to look for suitable treatment alternatives, which some of them find in private clinics abroad.

"Patients want to come as soon as the borders open," said Prof. Šarūnas Tarasevičius, chief surgeon at Nordorthopaedics clinic - leading international orthopaedic surgery center in Kaunas, Lithuania. "We already have Irish patients coming in June. As Lithuanian borders are open to all citizens of Ireland, some people from Northern Ireland also use this opportunity - they have Irish passports. We expect that other citizens of the UK will be free to travel in July. And by the end of the summer our clinic will have restored the pre-pandemic flow of patients."

According to Prof. Tarasevičius, the comparative safety of Lithuanian environment is one of the reasons why patients choose Nordorthopaedics clinic. Having successfully contained the pandemic Lithuania has a very low number of COVID-19 cases and is one of the safest travel destinations. Just recently the quarantine was lifted in Lithuania - another sign of an improving situation.

However, Nordorthopaedics clinic continues the safety measures that were introduced during the quarantine. These include COVID-19 testing all patients before surgeries, not allowing visitors or accompanying persons to the clinic as well as measures of hygiene and disinfection. Most preliminary consultations are handled online as patients submit their medical history through e-mail or other means of communication.

"Having worked with international patients for many years, we are used to online or e-mail consultations," explained Prof. Tarasevičius. "We are an experienced medical team and in most cases we prepare everything so that we proceed with surgery as soon as the patient arrives."

Prof. Tarasevičius has been practicing orthopaedic surgery for 15 years. He has conducted more than 2000 joint replacement surgeries and co-authored more than 150 scientific articles in different medical journals. His experience ensures the high quality of service at Nordorthopaedics clinic. The clinic offers hip and knee replacement packages that include 7-day or 14-day recovery in Druskininkai - a popular SPA resort in Lithuania. Hip replacement package with 7-day recovery starts at €7,500. Knee replacement package with 7-day recovery starts at €7,530. 

-END -

ABOUT NORDORTHOPAEDICS

Nordorthopaedics is a private clinic in Kaunas, Lithuania, part of Nordclinic, offering high-quality services and focusing on foreign patients. It is equipped with modern diagnostic and surgical facilities. Medical professionals at the clinic speak fluent English and show personal attention to every patient. www.nordorthopaedics.com/en.

50+ And Healthy Examines The Importance Of Mental Health As We Age

Chicago, IL, June 23, 2020 — The worldwide stay-at-home orders have turned weekend warriors into daily dog walkers, joggers and cyclists — all hoping to stay fit and avoid the “quarantine 15.” But there’s more to being healthy than having a fit physique. Mental health is equally important, but often gets buried beneath the stigma surrounding it.

“Many of you recognize that mental illness is often a taboo subject … due to seeming complexity, mystery and stigma,” explains Murali Rao, MD. “Unfortunately, the high discrimination of the subject leads to a statistic of nearly two-thirds of the world population refusing to seek help for mental health related issues.” Adding: “Though this primer is directed towards learning to help elders, the material can readily apply to any age group.”

Rao, an expert on clinical geriatrics and geriatric psychiatry, addresses the concepts of mental health and mental illnesses in the overarching context of healthy aging in 50+ and Healthy: What You Need to Know About Mental Health and Healthy Aging — for You and Your Loved Ones. This exceptionally strong, evidence-based guide emphasizes the importance of nurturing our mental health as we grow older.

Using easy-to-understand language, he explores common health-related conditions, how to recognize symptoms, practical approaches to treatments and his GAME PLANTMmethod for helping yourself and your loved ones, of any age, during times of distress or mental health crises. 

For readers of any educational and professional background, 50+ and Healthy offers easily presented information and relatable case studies.

With this book, you can learn from a world authority about: 

1. Healthy aging and mental health

2. Common mental illnesses, why people get them, how to identify them and how to manage them

3. Practical approaches for first aid and later interventions

4. Self-care for mental health and successful aging

If you are interested in healthy aging and how to help yourself, your family members and your friends with mental health, this book is for you. All proceeds from book sales go to a nonprofit organization engaged in mental health awareness education in the United States and India (www.nndcifoundation.org), founded by Dr. Murali Rao.

Author Murali Rao, MD, is a professor and chairman of the Department of Psychiatry and Behavioral Neurosciences at Loyola University Medical Center in Chicago. He specializes in liaison and emergency psychiatry. Additionally, he serves as a member of multiple professional bodies including the American College of Psychiatrists, the Academy of Psychosomatic Medicine, CINP, the Indian Psychiatric Society and serves on the Scientific Advisory Board of the Depression and Bipolar Support Alliance (DBSA).

Dr. Rao has received multiple awards and fellowships, including Distinguished Life Fellow by the APA, Outstanding Academician Award by the Indo-American Psychiatric Association and the Master Teacher Award by the Stritch School of Medicine. Dr. Rao has also had more than 80 journal publications, books and book-chapters. He has recently published trainee and trainer manuals on Adult Mental Health, Substance Abuse and Workplace Mental Health. 

For more information, please visit www.nndcifoundation.org, or follow the author on Twitter at @MuraliRaoMD. 

50 + and Healthy: What You Need to Know About Mental Health and Healthy Aging — for You and Your Loved Ones

Publisher: Loyola University Chicago

ISBN-10: 1735177504 

ISBN-13: 978-1735177502

Available from Amazon.com

###

Texas A&M System Brands Buildings at Texas A&M Innovation Plaza in Texas Medical Center

The five-acre mixed-use Texas A&M Innovation Plaza in Houston will be home to the Engineering Medicine program and more.

COLLEGE STATION, Texas — The Texas A&M University System has announced Discovery Tower, Life Tower and Horizon Tower as the names of the three buildings that comprise Texas A&M Innovation Plaza, its landmark 5-acre campus in Houston, Texas, at the prominent intersection of Holcombe Boulevard and Main Street near the Texas Medical Center (TMC). This campus sets a new standard for collaboration in engineering, medicine, research and education and is the first all-new mixed-use campus for the Texas A&M System in Houston.

The Texas A&M University System initiated the new campus by acquiring and renovating an 18-story office building at 1020 Holcombe Blvd. to be the home for EnMed, a unique two-degree program that provides students the chance to earn a master’s degree in engineering from Texas A&M University and a medical degree from the Texas A&M College of Medicine. Opening later this year, this building supports EnMed and an expanded array of Texas A&M’s engineering, research, innovation, medical and life science programs that are reflected in the newly announced brand:  Discovery Tower.

Complementing the academic, research, discovery and innovation missions of the EnMed Building, Texas A&M Innovation Plaza will provide a welcoming, secure and vibrant experience to the campus population and visitors alike, with generous green spaces and lifestyle amenities not commonly found in the TMC area.

With groundbreaking scheduled in late 2020, the System’s public-private partnership (P3) developer is bringing additional investment of $401 million to fulfill unmet needs in the area with two complementary towers totaling an additional 1.9 million square feet.

“EnMed is just the first example of innovation that Texas A&M System intends to bring to the Texas A&M Innovation Plaza,” said Texas A&M System Chancellor John Sharp. “We are excited to have such a visible location in the Texas Medical Center.”

Scheduled to be complete in June 2022, Life Tower is a 19-story, 714-bed student housing tower will overlook a scenic plaza flanked by a large garage with retail and dining at grade with convenient, affordable parking for 2,714 vehicles. Texas A&M medical students and Prairie View A&M University nursing students will be given priority for housing, but students from other institutions could fill open slots, if available. 

Scheduled to deliver in January 2024 is Horizon Tower, a 17-story, 485,000 square-foot integrated building that will be built atop the 13-story parking structure. With generous, efficient floorplates and robust building technologies, Horizon Tower will be ideally suited to life sciences, clinical, biomedical, technology and office uses.

Accessible via Main Street, Holcombe Boulevard and Fannin Street, Texas A&M Innovation Plaza is also adjacent to the METRO TMC Station, providing convenient connectivity via bus and light rail service to the TMC, Museum District and Downtown Houston.

The developer for the P3 projects is Medistar Corporation, a long-time Houston-based developer. Infrastructure investment firm American Triple I Partners, founded by Texas A&M alum Henry Cisneros, is part of the financing team.

About The Texas A&M University System
The Texas A&M University System is one of the largest systems of higher education in the nation with a budget of $6.3 billion. The System is a statewide network of 11 universities; a comprehensive health science center; eight state agencies, including the Texas Division of Emergency Management; and the RELLIS Campus. The Texas A&M System educates more than 151,000 students and makes more than 22 million additional educational contacts through service and outreach programs each year. System-wide, research and development expenditures exceeded $1 billion in FY 2019 and helped drive the state’s economy.